Melanoma of the glans penis successfully treated with topical imiquimod: dermoscopy usefulness in clinical monitoring and review of the literature

G Ital Dermatol Venereol. 2017 Dec;152(6):663-668. doi: 10.23736/S0392-0488.16.04789-1. Epub 2014 Sep 18.

Abstract

Melanoma in situ (MIS) of the penis is very rare in dermatologic literature. The standard of care for MIS is surgical removal by excision with a 5-mm margins or Mohs micrographic surgery. Nevertheless, surgery is occasionally not feasible for a number of reasons, such as patient comorbidities, potential aesthetic and functional impairment and patient preference. Recently, topical treatment with an immunomodulator, imiquimod, has been proposed as an alternative treatment for MIS. Dermoscopy, beyond its well established usefulness in the diagnostic evaluation of melanocytic lesions, has also shown to be an important tool in monitoring therapeutic response to various dermatoses. We present a case of a 38-year-old man who presented a MIS of the glans penis, histopathologically diagnosed, treated successfully using imiquimod.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Aminoquinolines / administration & dosage*
  • Antineoplastic Agents / administration & dosage
  • Dermoscopy / methods
  • Humans
  • Imiquimod
  • Male
  • Melanoma / diagnosis
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Penile Neoplasms / diagnosis
  • Penile Neoplasms / drug therapy*
  • Penile Neoplasms / pathology
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Treatment Outcome

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Imiquimod